Parthasarathi P CRMI It is the oral DOC in Visceral leishmaniasis
MILTEFOSIN It is also the DOC for post kala-azar
leishmaniasis E MOA : It interferes with lipid metabolism or prevent synthesis of critical cell surface anchor molecules or alter signal transduction. Side-effects • Persistent nausea • Vomiting • Diarrhoea • Skin allergy • Hepatic derangements • Rise in serum creatinine • C/I Pregnancy Dosage • . Miltefosine (all doses given orally with meals for 28 days) • Adults (>12 years) weighing > 25 kg : 100 mg/day (50 mg cap twice daily) • Adults (>12 years) weighing <25 kg: 50 mg/day (50 mg cap once daily) • Children (2-11 years): 2.5 mg/kg/day (as 10 mg caps) PRAZIQUANTEL • It is the antihelmintic drug used to treat cestodes and trematodes • Cestodes includes T.solium (intestinal form), T.saginata, H.nana, D.latum. • Trematodes include Schistosomes, Lung flukes, Liver flukes. MOA: It stimulates calcium channel and cause leakage of SIDE EFFECTS: intracellular calcium Impaired alertness, from membranes myalgiaz arthraliga producing contracture and cause spastic paralysis • CONTRAINDICATION: In ocular cysticercosis – cause blindness • DRUG INTERACTION: Phenytoin, carbamazepine and dexamethasone induce praziquantel metabolism . • Dosage depends on the parasite. THANK YOU